{"id":5467,"date":"2021-06-28T08:30:36","date_gmt":"2021-06-28T08:30:36","guid":{"rendered":"https:\/\/www.adacyte.com\/?post_type=scientific-corner&#038;p=5467"},"modified":"2024-05-02T09:58:49","modified_gmt":"2024-05-02T07:58:49","slug":"granulocyte-and-monocyte-apheresis-as-an-adjunctive-therapy-to-induce-and-maintain-clinical-remission-in-ulcerative-colitis-a-systematic-review-and-meta-analysis","status":"publish","type":"scientific-corner","link":"https:\/\/www.adacyte.com\/es\/professional\/scientific-corner\/granulocyte-and-monocyte-apheresis-as-an-adjunctive-therapy-to-induce-and-maintain-clinical-remission-in-ulcerative-colitis-a-systematic-review-and-meta-analysis\/","title":{"rendered":"Granulocyte and monocyte apheresis as an adjunctive therapy to induce and maintain clinical remission in ulcerative colitis: a systematic review and meta analysis"},"content":{"rendered":"<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Kiss+S&amp;cauthor_id=34011580\">Szabolcs Kiss<\/a>,&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=N%C3%A9meth+D&amp;cauthor_id=34011580\">D\u00e1vid N\u00e9meth<\/a>,&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Hegyi+P&amp;cauthor_id=34011580\">P\u00e9ter Hegyi<\/a><sup>&nbsp;<\/sup>,&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=F%C3%B6ldi+M&amp;cauthor_id=34011580\">M\u00e1ria F\u00f6ldi<\/a><sup>&nbsp;<\/sup>,&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Szak%C3%A1cs+Z&amp;cauthor_id=34011580\">Zsolt Szak\u00e1cs<\/a>,&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Er%C5%91ss+B&amp;cauthor_id=34011580\">B\u00e1lint Er\u0151ss<\/a><sup>&nbsp;<\/sup>,&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Tinusz+B&amp;cauthor_id=34011580\">Benedek Tinusz<\/a><sup>&nbsp;<\/sup>,&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Hegyi+PJ&amp;cauthor_id=34011580\">P\u00e9ter Jen\u0151 Hegyi<\/a>,&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Sarl%C3%B3s+P&amp;cauthor_id=34011580\">Patr\u00edcia Sarl\u00f3s<\/a><sup>&nbsp;<\/sup>,&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Alizadeh+H&amp;cauthor_id=34011580\">Hussain Alizadeh<\/a>, BMJ Open&nbsp;2021 May 19;11(5):e042374.<\/p>\n<\/div>\n\n<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p>The results support the hypothesis that patients with active UC have a better chance of clinical remission if GMA is administered as an adjunctive therapy. As regards the frequency of AEs, we found no statistically significant difference between the two groups. With regard to remission maintenance, GMA was identified as an effective alternative therapeutic option<\/p>\n<\/div>\n\n<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/34011580\/\" target=\"_blank\" rel=\"noreferrer noopener\">https:\/\/pubmed.ncbi.nlm.nih.gov\/34011580\/<\/a><\/p>\n<\/div>\n\n<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p><a href=\"https:\/\/bmjopen.bmj.com\/content\/bmjopen\/11\/5\/e042374.full.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">e042374.full.pdf (bmj.com)<\/a><\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>Szabolcs Kiss,&nbsp;D\u00e1vid N\u00e9meth,&nbsp;P\u00e9ter Hegyi&nbsp;,&nbsp;M\u00e1ria F\u00f6ldi&nbsp;,&nbsp;Zsolt Szak\u00e1cs,&nbsp;B\u00e1lint Er\u0151ss&nbsp;,&nbsp;Benedek Tinusz&nbsp;,&nbsp;P\u00e9ter Jen\u0151 Hegyi,&nbsp;Patr\u00edcia Sarl\u00f3s&nbsp;,&nbsp;Hussain Alizadeh, BMJ Open&nbsp;2021 May 19;11(5):e042374. The results support the hypothesis that patients with active UC have a better chance of clinical remission if GMA is administered as an adjunctive therapy. As regards the frequency of AEs, we found no statistically significant difference between the [&hellip;]<\/p>\n","protected":false},"template":"","scientific_tags":[147,303,157,321,424,322,312,140,156,306],"class_list":["post-5467","scientific-corner","type-scientific-corner","status-publish","hentry","scientific_tags-clinical-remission","scientific_tags-combination","scientific_tags-efficacy","scientific_tags-gastroenterology","scientific_tags-gma","scientific_tags-haematology","scientific_tags-immunology","scientific_tags-meta-analysis","scientific_tags-safety","scientific_tags-ulcerative-colitis"],"acf":{"sc_authors":"<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/34011580\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/34011580\/<\/a>\r\n\r\n<a href=\"https:\/\/bmjopen.bmj.com\/content\/bmjopen\/11\/5\/e042374.full.pdf\">https:\/\/bmjopen.bmj.com\/content\/bmjopen\/11\/5\/e042374.full.pdf<\/a>"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.9 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Granulocyte and monocyte apheresis as an adjunctive therapy to induce and maintain clinical remission in ulcerative colitis: a systematic review and meta analysis - Adacyte<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/granulocyte-and-monocyte-apheresis-as-an-adjunctive-therapy-to-induce-and-maintain-clinical-remission-in-ulcerative-colitis-a-systematic-review-and-meta-analysis\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Granulocyte and monocyte apheresis as an adjunctive therapy to induce and maintain clinical remission in ulcerative colitis: a systematic review and meta analysis - Adacyte\" \/>\n<meta property=\"og:description\" content=\"Szabolcs Kiss,&nbsp;D\u00e1vid N\u00e9meth,&nbsp;P\u00e9ter Hegyi&nbsp;,&nbsp;M\u00e1ria F\u00f6ldi&nbsp;,&nbsp;Zsolt Szak\u00e1cs,&nbsp;B\u00e1lint Er\u0151ss&nbsp;,&nbsp;Benedek Tinusz&nbsp;,&nbsp;P\u00e9ter Jen\u0151 Hegyi,&nbsp;Patr\u00edcia Sarl\u00f3s&nbsp;,&nbsp;Hussain Alizadeh, BMJ Open&nbsp;2021 May 19;11(5):e042374. The results support the hypothesis that patients with active UC have a better chance of clinical remission if GMA is administered as an adjunctive therapy. As regards the frequency of AEs, we found no statistically significant difference between the [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/granulocyte-and-monocyte-apheresis-as-an-adjunctive-therapy-to-induce-and-maintain-clinical-remission-in-ulcerative-colitis-a-systematic-review-and-meta-analysis\/\" \/>\n<meta property=\"og:site_name\" content=\"Adacyte\" \/>\n<meta property=\"article:modified_time\" content=\"2024-05-02T07:58:49+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/granulocyte-and-monocyte-apheresis-as-an-adjunctive-therapy-to-induce-and-maintain-clinical-remission-in-ulcerative-colitis-a-systematic-review-and-meta-analysis\/\",\"url\":\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/granulocyte-and-monocyte-apheresis-as-an-adjunctive-therapy-to-induce-and-maintain-clinical-remission-in-ulcerative-colitis-a-systematic-review-and-meta-analysis\/\",\"name\":\"Granulocyte and monocyte apheresis as an adjunctive therapy to induce and maintain clinical remission in ulcerative colitis: a systematic review and meta analysis - Adacyte\",\"isPartOf\":{\"@id\":\"https:\/\/www.adacyte.com\/#website\"},\"datePublished\":\"2021-06-28T08:30:36+00:00\",\"dateModified\":\"2024-05-02T07:58:49+00:00\",\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/granulocyte-and-monocyte-apheresis-as-an-adjunctive-therapy-to-induce-and-maintain-clinical-remission-in-ulcerative-colitis-a-systematic-review-and-meta-analysis\/\"]}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.adacyte.com\/#website\",\"url\":\"https:\/\/www.adacyte.com\/\",\"name\":\"Adacyte\",\"description\":\"Adacyte Therapeutics\",\"publisher\":{\"@id\":\"https:\/\/www.adacyte.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.adacyte.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.adacyte.com\/#organization\",\"name\":\"Adacyte\",\"url\":\"https:\/\/www.adacyte.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg\",\"contentUrl\":\"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg\",\"width\":165,\"height\":46,\"caption\":\"Adacyte\"},\"image\":{\"@id\":\"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Granulocyte and monocyte apheresis as an adjunctive therapy to induce and maintain clinical remission in ulcerative colitis: a systematic review and meta analysis - Adacyte","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/granulocyte-and-monocyte-apheresis-as-an-adjunctive-therapy-to-induce-and-maintain-clinical-remission-in-ulcerative-colitis-a-systematic-review-and-meta-analysis\/","og_locale":"es_ES","og_type":"article","og_title":"Granulocyte and monocyte apheresis as an adjunctive therapy to induce and maintain clinical remission in ulcerative colitis: a systematic review and meta analysis - Adacyte","og_description":"Szabolcs Kiss,&nbsp;D\u00e1vid N\u00e9meth,&nbsp;P\u00e9ter Hegyi&nbsp;,&nbsp;M\u00e1ria F\u00f6ldi&nbsp;,&nbsp;Zsolt Szak\u00e1cs,&nbsp;B\u00e1lint Er\u0151ss&nbsp;,&nbsp;Benedek Tinusz&nbsp;,&nbsp;P\u00e9ter Jen\u0151 Hegyi,&nbsp;Patr\u00edcia Sarl\u00f3s&nbsp;,&nbsp;Hussain Alizadeh, BMJ Open&nbsp;2021 May 19;11(5):e042374. The results support the hypothesis that patients with active UC have a better chance of clinical remission if GMA is administered as an adjunctive therapy. As regards the frequency of AEs, we found no statistically significant difference between the [&hellip;]","og_url":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/granulocyte-and-monocyte-apheresis-as-an-adjunctive-therapy-to-induce-and-maintain-clinical-remission-in-ulcerative-colitis-a-systematic-review-and-meta-analysis\/","og_site_name":"Adacyte","article_modified_time":"2024-05-02T07:58:49+00:00","twitter_card":"summary_large_image","twitter_misc":{"Tiempo de lectura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/granulocyte-and-monocyte-apheresis-as-an-adjunctive-therapy-to-induce-and-maintain-clinical-remission-in-ulcerative-colitis-a-systematic-review-and-meta-analysis\/","url":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/granulocyte-and-monocyte-apheresis-as-an-adjunctive-therapy-to-induce-and-maintain-clinical-remission-in-ulcerative-colitis-a-systematic-review-and-meta-analysis\/","name":"Granulocyte and monocyte apheresis as an adjunctive therapy to induce and maintain clinical remission in ulcerative colitis: a systematic review and meta analysis - Adacyte","isPartOf":{"@id":"https:\/\/www.adacyte.com\/#website"},"datePublished":"2021-06-28T08:30:36+00:00","dateModified":"2024-05-02T07:58:49+00:00","inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.adacyte.com\/professional\/scientific-corner\/granulocyte-and-monocyte-apheresis-as-an-adjunctive-therapy-to-induce-and-maintain-clinical-remission-in-ulcerative-colitis-a-systematic-review-and-meta-analysis\/"]}]},{"@type":"WebSite","@id":"https:\/\/www.adacyte.com\/#website","url":"https:\/\/www.adacyte.com\/","name":"Adacyte","description":"Adacyte Therapeutics","publisher":{"@id":"https:\/\/www.adacyte.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.adacyte.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.adacyte.com\/#organization","name":"Adacyte","url":"https:\/\/www.adacyte.com\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg","contentUrl":"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg","width":165,"height":46,"caption":"Adacyte"},"image":{"@id":"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.adacyte.com\/es\/wp-json\/wp\/v2\/scientific-corner\/5467","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.adacyte.com\/es\/wp-json\/wp\/v2\/scientific-corner"}],"about":[{"href":"https:\/\/www.adacyte.com\/es\/wp-json\/wp\/v2\/types\/scientific-corner"}],"wp:attachment":[{"href":"https:\/\/www.adacyte.com\/es\/wp-json\/wp\/v2\/media?parent=5467"}],"wp:term":[{"taxonomy":"scientific_tags","embeddable":true,"href":"https:\/\/www.adacyte.com\/es\/wp-json\/wp\/v2\/scientific_tags?post=5467"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}